INS and obesity disorder: Patients with obesity usually present accumulation of free fatty acids (FFAs) in liver, adipocytes, skeletal muscle, and pancreas (7), which causes lipotoxicity in pancreatic β-cells and inhibition of insulin signaling in the liver and muscles, along with the eventual occurrence of IR (8).